Hai Hua Jiang

733 citations
13 papers · 628 indexed · h-index 10
Topics
Cell death mechanisms and regulation (5 papers)Nanoparticle-Based Drug Delivery (4 papers)Diabetes Treatment and Management (4 papers)

In The Last Decade

Hai Hua Jiang

11 papers receiving 623 citations

Peers

Hai Hua Jiang
Comparison fields: 5 of 83
  • Molecular Biology 342
  • Biomaterials 190
  • Molecular Medicine 135
  • Pharmaceutical Science 109
  • Biomedical Engineering 84
Replace J. Narayanan with:
J. Narayanan India
Sharon Pangburn United States
Santosh S. Dhule United States
Gabriela Kolláriková Slovakia
Żaneta Kałuzińska‐Kołat Poland
Hamed Montazeri Iran
Dipankar Pramanik United States
Yifang Zou China
Zhipeng Li China
Hai Hua Jiang relative to J. Narayanan India J. Narayanan's profile →
Citations per field
00.5×10×20×30×40×45×
J. Narayanan · 1×
Citations per year

Countries citing papers authored by Hai Hua Jiang

Since Specialization
Citations

This map shows the geographic impact of Hai Hua Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hai Hua Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hai Hua Jiang more than expected).

Fields of papers citing papers by Hai Hua Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hai Hua Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hai Hua Jiang. The network helps show where Hai Hua Jiang may publish in the future.

Co-authorship network of co-authors of Hai Hua Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Hai Hua Jiang. A scholar is included among the top collaborators of Hai Hua Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hai Hua Jiang. Hai Hua Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 0
2 0
3 24
4 46
5 20
6 44
7 47
8 68
9 50
10 44
11 49
12 235
13 1

About Hai Hua Jiang

Hai Hua Jiang is a scholar working on Pharmaceutical Science, Biomaterials and Endocrinology, Diabetes and Metabolism, having authored 13 papers that have together received 628 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (5 papers), Nanoparticle-Based Drug Delivery (4 papers) and Diabetes Treatment and Management (4 papers). The work is most often cited by research in Molecular Medicine (135 citations), Pharmaceutical Science (109 citations) and Biomaterials (190 citations). Hai Hua Jiang has collaborated with scholars based in South Korea, United States and China. Frequent co-authors include Kang Choon Lee, Tae Hyung Kim, Seulki Lee, Yu Seok Youn, Xiaohong Chen, Chan Woong Park, Sung Mook Lim, Hyungjun Kim, Xiaoyuan Chen and Sangyong Jon. Their work appears in journals such as Biomaterials, Journal of Controlled Release and International Journal of Pharmaceutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026